세계의 지질 나노입자 시장 보고서(2025년)

Lipid nanoparticles are a class of nanoparticles primarily composed of lipids, essential fatty substances integral to cell membranes. These nanoparticles typically consist of a lipid bilayer or solid lipid matrix, characterized by their small size, typically ranging from 10 to 1000 nanometers in diameter.

The primary types of lipid nanoparticles include nanostructured lipid carriers (NLCs), solid lipid nanoparticles (SLNs), and other variations. Nanostructured lipid carriers (NLCs) are small structures composed of fats capable of encapsulating drugs or nutrients. They find applications in various fields including research and therapeutics and are utilized by diverse end-users such as pharmaceutical and biotechnology companies, academic and research institutions, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The lipid nanoparticles market research report is one of a series of new reports from The Business Research Company that provides lipid nanoparticles market statistics, including lipid nanoparticles industry global market size, regional shares, competitors with a lipid nanoparticles market share, detailed lipid nanoparticles market segments, market trends, and opportunities, and any further data you may need to thrive in the lipid nanoparticles industry. This lipid nanoparticles market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The lipid nanoparticles market size has grown rapidly in recent years. It will grow from $1.04 billion in 2024 to $1.21 billion in 2025 at a compound annual growth rate (CAGR) of 17.0%. The growth in the historic period can be attributed to rising focus on the development of LNP-based drugs, strong investment in research infrastructure, increasing healthcare expenditures.

The lipid nanoparticles market size is expected to see rapid growth in the next few years. It will grow to $2.16 billion in 2029 at a compound annual growth rate (CAGR) of 15.6%. The growth in the forecast period can be attributed to rising prevalence of chronic diseases, increasing demand for RNA-based therapeutics, increasing demand for advanced gene delivery systems, this increasing focus on personalized medicine, increasing investment in research and development. Major trends in the forecast period include advancements in drug delivery technologies, innovative drug delivery systems, integration of artificial intelligence in LNP development.

The forecast of 15.6% growth over the next five years reflects a modest reduction of 0.7% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. drug delivery innovation by increasing the cost of mRNA vaccine encapsulation materials sourced from Switzerland and South Korea, thereby delaying novel therapeutic development and elevating biomanufacturing costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of chronic diseases is fueling the expansion of the lipid nanoparticles (LNPs) market. Chronic diseases are long-term conditions lasting typically over three months and include illnesses such as diabetes and hypertension. The rates of chronic diseases are increasing due to factors such as unhealthy lifestyle choices, aging populations, tobacco use, poor nutrition, physical inactivity, and excessive alcohol consumption. Lipid nanoparticles (LNPs) present a viable solution in managing chronic diseases by enhancing the efficacy of mRNA therapeutics and vaccines. They are transforming the treatment landscape for chronic conditions, offering improved management options and potentially better outcomes for patients. For instance, according to the National Health Service (NHS), a UK government department, in June 2024, over half a million (549,000) additional individuals in England were identified in 2023 as at risk of developing type 2 diabetes. This raised the total number of individuals with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330-a nearly 20% increase from 3,065,825 in 2022. Thus, the rising incidence of chronic diseases is driving growth in the lipid nanoparticle market.

Key players in the lipid nanoparticles market are spearheading innovations in circular RNA (circRNA) and lipid nanoparticle (LNP) formulations to gain a competitive advantage. The advancement of circular RNA (circRNA) and lipid nanoparticle (LNP) formulations expands the repertoire of RNA formats, including circRNA, a single-stranded RNA characterized by a covalently closed loop structure. For instance, in September 2023, GenScript Biotech, a prominent US-based life sciences company, augmented its reagent services to encompass circular RNA (circRNA) and lipid nanoparticles (LNP) formulation. These enhanced services align with GenScript's commitment to providing protein replacement therapies, gene and cell therapy solutions, and are readily available as part of the company's contract-manufactured reagent services. CircRNA offers several advantages over traditional linear RNA, including heightened stability, slower degradation, and the potential to achieve therapeutic protein levels at lower dosages.

In February 2022, Merck & Co., Inc., a leading US-based pharmaceutical company, completed the acquisition of Exelead for $780 million in cash. This strategic acquisition bolsters Merck's Life Science division by enabling the provision of comprehensive contract development and manufacturing organization (CDMO) services across the mRNA value chain. Exelead, a reputable US-based biopharmaceutical CDMO, specializes in the production of PEGylated products and complex injectable formulations, including lipid nanoparticle (LNP) based drug delivery technology, augmenting Merck's capabilities in advancing innovative therapies for chronic diseases.

Major companies operating in the lipid nanoparticles (LNPs) market report are Pfizer Inc.; Johnson & Johnson; AbbVie Inc.; Bayer AG; Abbott Laboratories; Amgen Inc; The Merck Group; Evonik Industries AG; BioNTech SE; Moderna Inc.; Sanofi SA; Solid Biosciences Inc.; AstraZeneca PLC; NOF Corporation; Alnylam Pharmaceuticals Inc.; Nanomerics Ltd.; CordenPharma International; Nippon Fine Chemical; Helix Biotech Inc.; Dicerna Pharmaceuticals; Gattefosse SAS; Arbutus Biopharma; Avanti Polar Lipids; IOI Oleo GmbH; Evox Therapeutics Ltd.

North America was the largest region in the lipid nanoparticles market in 2024. The regions covered in the lipid nanoparticles market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the lipid nanoparticles market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The lipid nanoparticles market consists of sales of solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), and lipid-based nanoparticles (LBNPs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lipid Nanoparticles Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lipid nanoparticles market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lipid nanoparticles ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lipid nanoparticles market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Nano-Structured Lipid Carriers (NLCs); Solid Lipid Nanoparticles (SLNs); Other Types
• 2) By Application: Research; Therapeutics
• 3) By End User: Pharmaceutical And Biotechnology Companies; Academics And Research Centers; Other End Users
• Subsegments:
• 1) By Nano-Structured Lipid Carriers (NLCs): Hard NLCs; Soft NLCs
• 2) By Solid Lipid Nanoparticles (SLNs): Conventional SLNs; Modified SLNs
• 3) By Other Types: Lipid-Core Micelles; Liposomes
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; AbbVie Inc.; Bayer AG; Abbott Laboratories; Amgen Inc; The Merck Group; Evonik Industries AG; BioNTech SE; Moderna Inc.; Sanofi SA; Solid Biosciences Inc.; AstraZeneca PLC; NOF Corporation; Alnylam Pharmaceuticals Inc.; Nanomerics Ltd.; CordenPharma International; Nippon Fine Chemical; Helix Biotech Inc.; Dicerna Pharmaceuticals; Gattefosse SAS; Arbutus Biopharma; Avanti Polar Lipids; IOI Oleo GmbH; Evox Therapeutics Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Lipid Nanoparticles Market Characteristics

3. Lipid Nanoparticles Market Trends And Strategies

4. Lipid Nanoparticles Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Lipid Nanoparticles Growth Analysis And Strategic Analysis Framework

• 5.1. Global Lipid Nanoparticles PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Lipid Nanoparticles Market Growth Rate Analysis
• 5.4. Global Lipid Nanoparticles Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Lipid Nanoparticles Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Lipid Nanoparticles Total Addressable Market (TAM)

6. Lipid Nanoparticles Market Segmentation

• 6.1. Global Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nano-Structured Lipid Carriers (NLCs)
• Solid Lipid Nanoparticles (SLNs)
• Other Types
• 6.2. Global Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Research
• Therapeutics
• 6.3. Global Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical And Biotechnology Companies
• Academics And Research Centers
• Other End Users
• 6.4. Global Lipid Nanoparticles Market, Sub-Segmentation Of Nano-Structured Lipid Carriers (NLCs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hard NLCs
• Soft NLCs
• 6.5. Global Lipid Nanoparticles Market, Sub-Segmentation Of Solid Lipid Nanoparticles (SLNs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Conventional SLNs
• Modified SLNs
• 6.6. Global Lipid Nanoparticles Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lipid-Core Micelles
• Liposomes

7. Lipid Nanoparticles Market Regional And Country Analysis

• 7.1. Global Lipid Nanoparticles Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Lipid Nanoparticles Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Lipid Nanoparticles Market

• 8.1. Asia-Pacific Lipid Nanoparticles Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Lipid Nanoparticles Market

• 9.1. China Lipid Nanoparticles Market Overview
• 9.2. China Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Lipid Nanoparticles Market

• 10.1. India Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Lipid Nanoparticles Market

• 11.1. Japan Lipid Nanoparticles Market Overview
• 11.2. Japan Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Lipid Nanoparticles Market

• 12.1. Australia Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Lipid Nanoparticles Market

• 13.1. Indonesia Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Lipid Nanoparticles Market

• 14.1. South Korea Lipid Nanoparticles Market Overview
• 14.2. South Korea Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Lipid Nanoparticles Market

• 15.1. Western Europe Lipid Nanoparticles Market Overview
• 15.2. Western Europe Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Lipid Nanoparticles Market

• 16.1. UK Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Lipid Nanoparticles Market

• 17.1. Germany Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Lipid Nanoparticles Market

• 18.1. France Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Lipid Nanoparticles Market

• 19.1. Italy Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Lipid Nanoparticles Market

• 20.1. Spain Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Lipid Nanoparticles Market

• 21.1. Eastern Europe Lipid Nanoparticles Market Overview
• 21.2. Eastern Europe Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Lipid Nanoparticles Market

• 22.1. Russia Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Lipid Nanoparticles Market

• 23.1. North America Lipid Nanoparticles Market Overview
• 23.2. North America Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Lipid Nanoparticles Market

• 24.1. USA Lipid Nanoparticles Market Overview
• 24.2. USA Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Lipid Nanoparticles Market

• 25.1. Canada Lipid Nanoparticles Market Overview
• 25.2. Canada Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Lipid Nanoparticles Market

• 26.1. South America Lipid Nanoparticles Market Overview
• 26.2. South America Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Lipid Nanoparticles Market

• 27.1. Brazil Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Lipid Nanoparticles Market

• 28.1. Middle East Lipid Nanoparticles Market Overview
• 28.2. Middle East Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Lipid Nanoparticles Market

• 29.1. Africa Lipid Nanoparticles Market Overview
• 29.2. Africa Lipid Nanoparticles Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Lipid Nanoparticles Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Lipid Nanoparticles Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Lipid Nanoparticles Market Competitive Landscape And Company Profiles

• 30.1. Lipid Nanoparticles Market Competitive Landscape
• 30.2. Lipid Nanoparticles Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Lipid Nanoparticles Market Other Major And Innovative Companies

• 31.1. Amgen Inc.
• 31.2. The Merck Group
• 31.3. Evonik Industries AG
• 31.4. BioNTech SE
• 31.5. Moderna Inc.
• 31.6. Sanofi SA
• 31.7. Solid Biosciences Inc.
• 31.8. AstraZeneca PLC
• 31.9. NOF Corporation
• 31.10. Alnylam Pharmaceuticals Inc.
• 31.11. Nanomerics Ltd.
• 31.12. CordenPharma International
• 31.13. Nippon Fine Chemical
• 31.14. Helix Biotech Inc.
• 31.15. Dicerna Pharmaceuticals

32. Global Lipid Nanoparticles Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Lipid Nanoparticles Market

34. Recent Developments In The Lipid Nanoparticles Market

35. Lipid Nanoparticles Market High Potential Countries, Segments and Strategies

• 35.1 Lipid Nanoparticles Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Lipid Nanoparticles Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Lipid Nanoparticles Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer